from an...

from an earlierann

https://www.globenewswire.com/fr/news-release/2020/04/20/2018574/0/en/Recce-Pharmaceuticals-Announces-Positive-Data-on-RECCE-327-Against-Influenza-A-Respiratory-Virus-Infection-in-Animal-Model.html

Influenza A viruses are enveloped viruses and causative agents of respiratory disease. The genome of the Influenza A viruses comprises single-stranded ribonucleic acid (RNA) molecules – similar to that of coronaviruses, where the genome also comprises single-stranded RNA.Michele Dilizia, Executive Director of Regulatory Affairs, said, “These data reinforce RECCE® 327’s unique, universal mechanism of action, seen against bacterial cells and further now, viral particles. The universal mechanism of action shows continued potency against mutating bacterial cells and it is exciting to see the potential here as well, against viral particles, which are also notorious for their mutation.”Dr John Prendergast, Non-Executive Chairman said, “The increasing potential to be effective against not only a broad range of superbug bacteria, but viral pathogens as well, reinforces the company’s expanding infectious disease capabilities and global positioning.”